An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy.

MLA

Brišar, Nuša, et al. “An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy.” Viruses (1999-4915), vol. 16, no. 2, Feb. 2024, p. 232. EBSCOhost, https://doi.org/10.3390/v16020232.

APA

Brišar, N., Šuster, K., Brezar, S. K., Vidmar, R., Fonović, M., & Cör, A. (2024). An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy. Viruses (1999-4915), 16(2), 232. https://doi.org/10.3390/v16020232

Chicago

Brišar, Nuša, Katja Šuster, Simona Kranjc Brezar, Robert Vidmar, Marko Fonović, and Andrej Cör. 2024. “An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy.” Viruses (1999-4915) 16 (2): 232. doi:10.3390/v16020232.